Person:
Zaganjor, Elma

Profile Picture

Email Address

AA Acceptance Date

Birth Date

Research Projects

Organizational Units

Job Title

Last Name

Zaganjor

First Name

Elma

Name

Zaganjor, Elma

Filters

2017 - 20182

Settings

Author's Publications: search.filters.isAuthorOfPublication.9f037cee-4aed-432a-87f9-c9a5d8b887a3

Search Results

Now showing 1 - 2 of 2
  • Thumbnail Image
    Publication
    Strength in numbers: Phosphofructokinase polymerization prevails in the liver
    (The Rockefeller University Press, 2017) Zaganjor, Elma; Spinelli, Jessica; Haigis, Marcia
    Numerous metabolic enzymes assemble into filamentous structures, which are thought to serve additional regulatory functions. In this issue, Webb et al. (2017. J. Cell Biol. https://doi.org/10.1083/jcb.201701084) show that the liver-specific isoform of phosphofructokinase-1 forms filaments in vitro and localizes as puncta in cells along the plasma membrane. This suggests spatial organization of glycolysis in higher organisms.
  • Thumbnail Image
    Publication
    Small-Molecule Screen Identifies De Novo Nucleotide Synthesis as a Vulnerability of Cells Lacking SIRT3
    (2018) Gonzalez Herrera, Karina; Zaganjor, Elma; Ishikawa, Yoshinori; Spinelli, Jessica; Yoon, Haejin; Lin, Jia-Ren; Satterstrom, F. Kyle; Ringel, Alison; Mulei, Stacy; Souza, Amanda; Gorham, Joshua; Benson, Craig C.; Seidman, Jonathan; Sorger, Peter; Clish, Clary B.; Haigis, Marcia
    Summary Sirtuin 3 (SIRT3) is a NAD+-dependent deacetylase downregulated in aging and age-associated diseases such as cancer and neurodegeneration and in high-fat diet (HFD)-induced metabolic disorders. Here, we performed a small-molecule screen and identified an unexpected metabolic vulnerability associated with SIRT3 loss. Azaserine, a glutamine analog, was the top compound that inhibited growth and proliferation of cells lacking SIRT3. Using stable isotope tracing of glutamine, we observed its increased incorporation into de novo nucleotide synthesis in SIRT3 knockout (KO) cells. Furthermore, we found that SIRT3 KO cells upregulated the diversion of glutamine into de novo nucleotide synthesis through hyperactive mTORC1 signaling. Overexpression of SIRT3 suppressed mTORC1 and growth in vivo in a xenograft tumor model of breast cancer. Thus, we have uncovered a metabolic vulnerability of cells with SIRT3 loss by using an unbiased small-molecule screen.